HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
4317studies shown
Showing 433-444 of 4,317
Behavioral study icon
RecruitingNCT07092345

Adaptive family support after emergency care for suicidal youth

About this title

An Adaptive Intervention to Increase Engagement to Community-Based Care After an ED Admission

Read the official source — NCT07092345
Official study title

An Adaptive Intervention to Increase Engagement to Community-based Care After an ED Admission: For Youth at Risk for Suicide and Self-injurious Behavior

In Providence
SuicidalityBehavioural studyAges 8–17
Countries
United States
Sponsor
Rhode Island Hospital
Drug study icon
RecruitingEUCTR 2017-001170-42

An adaptive Phase II/III, Double-Blind, Randomized, Placebo-controlled, Two-Part, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase In...

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

Multiple locations, including Gdańsk
SchizophreniaHistorical research record
Countries
Poland
Sponsor
SyneuRx International (Taiwan) Corp
Drug study icon
RecruitingNCT03094429

Study of NaBen added to clozapine for resistant schizophrenia

About this title

An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults

Read the official source — NCT03094429
What is this study about?

This study evaluates the safety and effectiveness of NaBen® for people with schizophrenia.

In Pasadena
SchizophreniaMedication studyAges 18–55
Countries
United States
Sponsor
SyneuRx International (Taiwan) Corp
Drug study icon
RecruitingNCT07288320

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolarity type I With Current Mania

What is this study about?

Researchers compare NBI-1117568 with placebo to find out whether it reduces manic symptoms in adults with bipolarity type I who are experiencing mania, with or without mixed features. They also assess safety and how the medicine behaves in the body.

Multiple locations, including Little Rock
BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
Neurocrine Biosciences (Biotech company)
Behavioral study icon
RecruitingACTRN12615000684527

An effect of antenatal and postnatal maternal support programs on attachment and resilience for mums and infants: A Controlled study.

Official study title

An effect of antenatal and postnatal maternal support programs on mental health and mother-infant attachment in comparison to standard care in pregnant women at risk for mental illness: A Randomised Controlled Trial.

In Parkville
Personality disorders, Schizophrenia, ...Interventional studyAges 18+
Countries
Australia
Sponsor
Professor Louise Newman
Behavioral study icon
RecruitingNCT06853314

WINGS+PrEP support for HIV prevention among women facing alcohol use and partner violence

About this title

An Effectiveness Trial of the PrEP for WINGS Study

Read the official source — NCT06853314
Official study title

An Effectiveness Trial of WINGS+PrEP: a Syndemic mHealth Intervention to Increase PrEP Uptake Among Women Impacted by Heavy Alcohol Use and Partner Violence in the Criminal Legal System

In New York
AddictionBehavioural studyAges 18+
Countries
United States
Sponsor
Columbia University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.